Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1987 Jul;56(1):79–82. doi: 10.1038/bjc.1987.158

Chronic lymphocytic leukaemia: case control epidemiological study in Yorkshire.

R A Cartwright, S M Bernard, C C Bird, C M Darwin, C O'Brien, I D Richards, B Roberts, P A McKinney
PMCID: PMC2001663  PMID: 3304389

Abstract

This is the second report of a large case control study of lymphoma/leukaemia occurring in Yorkshire during 1979-84, and deals with chronic lymphocytic leukaemia presenting either in its haematological (CLL) or more solid lymphomatous (malignant lymphoma-lymphocytic or MLL) forms. In all, 330 cases and 561 controls were interviewed. The results support the concept that CLL/MLL is a condition of multiple aetiologies with evidence for genetic predisposition through an excess of family cases, immune perturbation demonstrated by excessive previous skin diseases and phenylbutazone use, and viral involvement shown by links with infectious diseases and multiple sclerosis.

Full text

PDF
79

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bartal A., Bentwich Z., Manny N., Izak G. Ethnical and clinical aspects of chronic lymphocytic leukemia in Israel: a survey on 288 patients. Acta Haematol. 1978;60(3):161–171. doi: 10.1159/000207712. [DOI] [PubMed] [Google Scholar]
  2. Bernard S. M., Cartwright R. A., Bird C. C., Richards I. D., Lauder I., Roberts B. E. Aetiologic factors in lymphoid malignancies: a case-control epidemiological study. Leuk Res. 1984;8(4):681–689. doi: 10.1016/0145-2126(84)90016-x. [DOI] [PubMed] [Google Scholar]
  3. Conley C. L., Misiti J., Laster A. J. Genetic factors predisposing to chronic lymphocytic leukemia and to autoimmune disease. Medicine (Baltimore) 1980 Sep;59(5):323–334. doi: 10.1097/00005792-198009000-00001. [DOI] [PubMed] [Google Scholar]
  4. Friedman G. D. Phenylbutazone, musculoskeletal disease, and leukemia. J Chronic Dis. 1982;35(4):233–243. doi: 10.1016/0021-9681(82)90079-0. [DOI] [PubMed] [Google Scholar]
  5. Gibson R., Graham S., Lilienfeld A., Schuman L., Levin M., Swanson M. Epidemiology of diseases in adult males with leukemia. J Natl Cancer Inst. 1976 May;56(5):891–898. doi: 10.1093/jnci/56.5.891. [DOI] [PubMed] [Google Scholar]
  6. Gunz F. W., Gunz J. P., Veale A. M., Chapman C. J., Houston I. B. Familial leukaemia: a study of 909 families. Scand J Haematol. 1975 Sep;15(2):117–131. doi: 10.1111/j.1600-0609.1975.tb01063.x. [DOI] [PubMed] [Google Scholar]
  7. Karchmer R. K., Mellman J. A., Caldwell G. G., Chin T. D. Previous and simultaneous cancers in patients with leukemia. J Chronic Dis. 1974 Feb;27(1):5–13. doi: 10.1016/0021-9681(74)90003-4. [DOI] [PubMed] [Google Scholar]
  8. Koprowski H., DeFreitas E. C., Harper M. E., Sandberg-Wollheim M., Sheremata W. A., Robert-Guroff M., Saxinger C. W., Feinberg M. B., Wong-Staal F., Gallo R. C. Multiple sclerosis and human T-cell lymphotropic retroviruses. Nature. 1985 Nov 14;318(6042):154–160. doi: 10.1038/318154a0. [DOI] [PubMed] [Google Scholar]
  9. Linos A., Kyle R. A., O'Fallon W. M., Kurland L. T. Leukemia and prior malignant and hematologic diseases: a case-control study. Am J Epidemiol. 1981 Mar;113(3):285–289. doi: 10.1093/oxfordjournals.aje.a113098. [DOI] [PubMed] [Google Scholar]
  10. Phadke J. G., Downie A. W. Epidemiology of multiple sclerosis in the north-east (Grampian region) of Scotland--an update. J Epidemiol Community Health. 1987 Mar;41(1):5–13. doi: 10.1136/jech.41.1.5. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES